BMJ

1. NUZZO JB
   Defunding mRNA vaccine research leaves us all more vulnerable to future health emergencies.
   BMJ. 2025;391:r2183.
   

   >> Share

   
   

   
   Clin Infect Dis

2. TARTOF SY, Aliabadi N, Goodwin G, Slezak J, et al
   Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season.
   Clin Infect Dis. 2025 Oct 21:ciaf496. doi: 10.1093.
   

   >> Share

   
   

   
   J Infect

3. BORROW R, Caugant DA, Clark SA, Dinleyici EC, et al
   Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal Initiative.
   J Infect. 2025 Oct 17:106635. doi: 10.1016/j.jinf.2025.106635.
   

   >> Share

   
   

   
   J Virol

4. DANGI T, Li S, Penaloza-MacMaster P
   Development of a cross-protective common cold coronavirus vaccine.
   J Virol. 2025 Oct 22:e0152625. doi: 10.1128/jvi.01526.
   

   >> Share

   
   
5. RZYMSKI P, Poniedzialek B, Zarebska-Michaluk D, Tomasiewicz K, et al
   High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?
   J Virol. 2025;99:e0143225.
   

   >> Share

   
   
6. JIAO Z, Li J, Wang P, Yan Y, et al
   Mutations in feline infectious peritonitis virus nonstructural protein 14/16 methyltransferase attenuate the pathogenicity of the virus in cats.
   J Virol. 2025 Sep 9:e0083925. doi: 10.1128/jvi.00839.
   

   >> Share

   
   

   
   Lancet

7. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
   Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis.
   Lancet. 2025 Oct 17:S0140-6736(25)01742-8. doi: 10.1016/S0140-6736(25)01742.
   

   >> Share

   
   

   
   PLoS One

8. NADERIAN R, Ahmad S, Rahmanian M, Aghaamoo S, et al
   Rational design of multi-epitope vaccine for Chandipura virus using an immunoinformatics approach.
   PLoS One. 2025;20:e0335147.
   

   >> Share

   
   

   
   Proc Natl Acad Sci U S A

9. 
   Correction to Supporting Information for Milkman et al., A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
   Proc Natl Acad Sci U S A. 2025;122:e2527439122.
   

   >> Share

   
   

   
   Science

10. CAPLAN A
    Vaccinations for allFair Doses Seth Berkley University of California Press, 2025. 408 pp.
    Science. 2025;390:342.
    

    >> Share

    
    
11. JACOBS P
    COVID-19 vaccines may boost cancer immunotherapy.
    Science. 2025;390:321-322.
    

    >> Share

    
    

    
    Vaccine

12. ASHWINI MA, Gupta S, Lodha L, Ramachandran A, et al
    Immunogenicity of the abbreviated one-week intradermal rabies pre-exposure prophylaxis and its boostability in health-care workers: A retrospective observational cohort study.
    Vaccine. 2025;65:127787.
    

    >> Share

    
    
13. OPHIR Y, Wong JH, Haddad KR, Huuskonen A, et al
    Expression and characterization of SARS-CoV-2 spike protein in Thermothelomyces heterothallica C1.
    Vaccine. 2025;65:127784.
    

    >> Share

    
    
14. MATTINGLY TJ 2ND
    Penny wise, pound foolish: The cost of reduced support for measles prevention.
    Vaccine. 2025;65:127830.
    

    >> Share

    
    
15. CARACO Y, Madar-Balakirski N, Ben-Ami E, Zeltser D, et al
    Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.
    Vaccine. 2025;67:127837.
    

    >> Share

    
    
16. CIMA MJ, Joshua C, Zohoori N, Porter A 3rd, et al
    Hesitancy towards routine childhood vaccinations before and after the COVID-19 pandemic in Arkansas.
    Vaccine. 2025;66:127834.
    

    >> Share

    
    
17. LIU B, Huang N, Liu Y, Zhang X, et al
    Parental perceptions and willingness to pay for childhood vaccination experiences in China: a multi-city comprehensive evaluation study.
    Vaccine. 2025;67:127826.
    

    >> Share

    
    
18. KILLANDER MOLLER I, Hedberg P, Wagner P, Sparen P, et al
    Corrigendum to "Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: Insights from a Swedish Nationwide cohort" [Vaccine 62 (2025) 127580].
    Vaccine. 2025;67:127855.
    

    >> Share

    
    
19. OIKAWA K, Murakami M, Ochi S, Yamagata M, et al
    Contributing factors to reversed willingness to vaccinate after the COVID-19 pandemic: Insights from a national panel survey.
    Vaccine. 2025;67:127869.
    

    >> Share

    
    
20. MOHANTY S, Zurovac J, Barna M, Cossrow N, et al
    Corrigendum to "Changes in pneumococcal vaccination disparities by area-level social vulnerability during the COVID-19 pandemic among Medicare and Medicaid enrollees" [Vaccine 62 (2025) 127452].
    Vaccine. 2025;67:127875.
    

    >> Share

    
    
21. ANOSIKE C, Ojiakor IM, Etiaba EI, Uguru NP, et al
    Cost-effectiveness and budget impact of malaria, measles, and meningitis vaccines in Africa: a scoping review.
    Vaccine. 2025;67:127853.
    

    >> Share

    
    
22. MERCADANTE E, Minssen T, Shadlen KC, van Zimmeren E, et al
    A global landscape of patenting activity in COVID-19 vaccines.
    Vaccine. 2025;67:127866.
    

    >> Share

    
    
23. HAPOSAN JH, Icanervilia AV, Watts E, Widyaningsih SA, et al
    Real-world vaccine effectiveness of typhoid conjugate vaccine in children and adolescents: a systematic review and meta-analysis.
    Vaccine. 2025;67:127872.
    

    >> Share

    
    
24. MALTEZOU HC, Drositis I, Sourri F, Tseroni M, et al
    Understanding the attitudes of unvaccinated COVID-19 patients hospitalized in Greece toward the 2024-2025 booster COVID-19 vaccine.
    Vaccine. 2025;67:127829.
    

    >> Share

    
    
25. YAO N, Liu Y, Zhang YY, Wang Q, et al
    Impacts of two-dose mumps-containing vaccine strategy on mumps incidence using segmented regression models.
    Vaccine. 2025;67:127874.
    

    >> Share

    
    
26. CAO BK, Nguyen TPL, Postma MJ, van der Schans J, et al
    Acceptance and willingness to pay for pneumococcal vaccination in Vietnam: insights into adult preferences and influencing factors.
    Vaccine. 2025;67:127884.
    

    >> Share

    
    
27. EAGAN RL, Claessens T, Hendrickx G, Larson HJ, et al
    The state of vaccine confidence among the general public in Eastern Europe and Central Asia.
    Vaccine. 2025;67:127849.
    

    >> Share

    
    
28. BOSETTI P, Peckeu-Abboud L, Andrianasolo RM, Baguelin M, et al
    Modelling the impact of a quadrivalent ACWY meningococcal vaccination and vaccination targeting serogroup B in France.
    Vaccine. 2025;67:127871.
    

    >> Share

    
    
29. STEINER A, Settgast A, DeSilva M, Payton C, et al
    Tetanus and diphtheria vaccination coverage and electronic health record alerts for immigrants and refugees at three United States health systems, 2017-2023.
    Vaccine. 2025;67:127881.
    

    >> Share

    
    
30. PORTER A, Cooper S, King A, Presti C, et al
    Regional voices, different choices: Parents' and caregivers' HPV vaccine attitudes in the northeast and Southeast United States.
    Vaccine. 2025;67:127864.
    

    >> Share

    
    
31. ZHANG X, Li Y, Tian J, Zhang M, et al
    Recombinant truncated gD glycoprotein from E.coli as a thermostable and protective subunit vaccine candidate against ILTV in chickens.
    Vaccine. 2025;67:127882.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share